Free Trial

INSPECS Group (SPEC) Competitors

INSPECS Group logo
GBX 43.22 -0.78 (-1.77%)
As of 05:21 AM Eastern

SPEC vs. TSTL, BVC, AKR, CNSL, ODX, CTEC, AMS, CIR, BVXP, and EKF

Should you be buying INSPECS Group stock or one of its competitors? The main competitors of INSPECS Group include Tristel (TSTL), BATM Advanced Communications (BVC), Akers Biosciences (AKR), Cambridge Nutritional Sciences (CNSL), Omega Diagnostics Group (ODX), ConvaTec Group (CTEC), Advanced Medical Solutions Group (AMS), Circassia Group (CIR), Bioventix (BVXP), and EKF Diagnostics (EKF). These companies are all part of the "medical" sector.

INSPECS Group vs. Its Competitors

INSPECS Group (LON:SPEC) and Tristel (LON:TSTL) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

Tristel has a net margin of 15.47% compared to INSPECS Group's net margin of -2.10%. Tristel's return on equity of 20.43% beat INSPECS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
INSPECS Group-2.10% -4.00% 0.45%
Tristel 15.47%20.43%9.89%

Tristel has a consensus price target of GBX 400, indicating a potential upside of 10.50%. Given Tristel's stronger consensus rating and higher possible upside, analysts plainly believe Tristel is more favorable than INSPECS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
INSPECS Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Tristel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, INSPECS Group's average media sentiment score of 0.00 equaled Tristel'saverage media sentiment score.

Company Overall Sentiment
INSPECS Group Neutral
Tristel Neutral

INSPECS Group pays an annual dividend of GBX 1 per share and has a dividend yield of 2.3%. Tristel pays an annual dividend of GBX 13 per share and has a dividend yield of 3.6%. INSPECS Group pays out -24.8% of its earnings in the form of a dividend. Tristel pays out 95.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

INSPECS Group has a beta of 2.22, indicating that its stock price is 122% more volatile than the S&P 500. Comparatively, Tristel has a beta of 0.23, indicating that its stock price is 77% less volatile than the S&P 500.

Tristel has lower revenue, but higher earnings than INSPECS Group. INSPECS Group is trading at a lower price-to-earnings ratio than Tristel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
INSPECS Group£195.14M0.23-£4.11M-£4.04-10.70
Tristel£42.24M4.09£6.54M£13.6626.49

67.8% of INSPECS Group shares are owned by institutional investors. Comparatively, 50.4% of Tristel shares are owned by institutional investors. 25.6% of INSPECS Group shares are owned by company insiders. Comparatively, 4.9% of Tristel shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Summary

Tristel beats INSPECS Group on 10 of the 15 factors compared between the two stocks.

Get INSPECS Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPEC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPEC vs. The Competition

MetricINSPECS GroupMedical Instruments & Supplies IndustryMedical SectorLON Exchange
Market Cap£43.94M£3.12B£5.76B£3.17B
Dividend Yield2.00%1.99%3.95%5.04%
P/E Ratio-10.7017.4331.45169.23
Price / Sales0.23297.23431.04465,108.52
Price / Cash1.63146.5437.7527.93
Price / Book0.432.2810.536.89
Net Income-£4.11M£99.80M£3.28B£5.89B
7 Day Performance-0.76%-0.14%0.37%0.23%
1 Month Performance-0.64%-1.55%5.15%50.01%
1 Year Performance-17.68%115.90%50.24%150.47%

INSPECS Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPEC
INSPECS Group
N/AGBX 43.22
-1.8%
N/A-16.9%£43.94M£195.14M-10.701,673
TSTL
Tristel
1.0792 of 5 stars
GBX 355
-1.4%
GBX 400
+12.7%
-25.6%£169.59M£42.24M25.98208
BVC
BATM Advanced Communications
N/AGBX 16
+1.1%
N/A-22.3%£84.97M£130.32M-371.44980News Coverage
AKR
Akers Biosciences
N/AN/AN/AN/A£21.64M£2.32M-0.44120
CNSL
Cambridge Nutritional Sciences
N/AGBX 3.08
-5.4%
N/A-15.1%£7.32M£9.77M-362.103,200Gap Down
ODX
Omega Diagnostics Group
N/AN/AN/AN/A£5.23M£7.55M-220.0091Gap Down
CTEC
ConvaTec Group
4.1781 of 5 stars
GBX 233.40
flat
GBX 309.40
+32.6%
-0.7%£5.94B£2.71B39.3110,000Insider Trade
AMS
Advanced Medical Solutions Group
2.185 of 5 stars
GBX 204
-0.5%
GBX 287.50
+40.9%
-17.1%£440.49M£132.18M39.5310News Coverage
Positive News
CIR
Circassia Group
N/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down
BVXP
Bioventix
N/AGBX 2,511
-0.6%
N/A-40.4%£131.48M£13.65M16.2412
EKF
EKF Diagnostics
N/AGBX 29.50
flat
N/A+8.9%£131.12M£49.91M27.45356

Related Companies and Tools


This page (LON:SPEC) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners